Loading...
Loading...
Among the 2 tracked institutional investors we monitor, SLXN (SILEXION THERAPEUTICS CORP) is held with a combined value of $27.04K across 33,426 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $26.79K (0.00% of their portfolio). 1 fund increased its holdings.
Total Institutional Value
$27.04K
Total Shares Held
33,426
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $26.79K | 0.00% | +71.5% |
| 2 | MILLENNIUM MANAGEMENT LLC | $254 | 0.00% | - |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of SLXN with a position worth $26.79K, representing 0.00% of their portfolio. In total, 2 institutional investors hold SLXN with a combined value of $27.04K.
Institutional investors hold $27.04K worth of SLXN stock across 2 positions. The largest institutional holder is CITADEL ADVISORS LLC with $26.79K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SLXN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SLXN positions.